This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of compounds targeting central nervous system disorders, such as antidepressants and anxiolytics, due to its structural properties that can influence neurotransmitter activity. Additionally, its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting drugs, making it a crucial component in medicinal chemistry research. It is also explored in the development of agrochemicals, where its unique structure contributes to the efficacy of pesticides and herbicides.